BioSpace News Archive

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced full enrollment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced financial results for the second quarter of 2022.

Health Canada has granted a Notice of Compliance with Conditions (NOC/c) for Lynparza ® (olaparib) for the adjuvant treatment of adult patients with deleterious or suspected deleterious germline BRCA -mutated (g BRCA m),

PsiOxus Therapeutics, Ltd. today announces the appointment of Howard Davis, Ph.D., as Chief Executive Officer.

UroGen Pharma Ltd. today announced financial results for the second quarter ended June 30, 2022 and provided an overview of recent developments.

Aptevo Therapeutics Inc. today reported financial results and business highlights for the quarter ended June 30, 2022.

Kaléo, a fully integrated pharmaceutical company dedicated to inventing, manufacturing, and commercializing life-transforming products for certain serious and life-threatening medical conditions, announced the appointment of a Chief Commercial Officer as well as the formation of a new Government Sector business unit.

Lucid Diagnostics Inc., a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc., announced that its subsidiary, LucidDx Labs Inc., has launched four new Lucid Test Centers in Orange County, California, the Dallas-Fort Worth, Texas metropolitan area, Palm Beach County, Florida and Columbus, Ohio.

NetworkNewsAudio – Lexaria Bioscience Corp. announces the availability of a broadcast titled, “The Power of Science to Stop a Killer.”.

Eli Lilly and Company (NYSE: LLY) today announced the upcoming retirement of one executive committee member, the naming of his successor, and the hiring of a new chief commercial officer for Loxo@Lilly.